Oncology and Immunology Innovation Partnering
11 11 people viewed this event.
Advance Best- or First- in Class Candidates, Demonstrate Differentiation and Validate Technologies
Within these hyper-competitive landscapes, differentiating assets targeting proven targets, balancing efficacy with worsening toxicity, or securing minimum evidence to validate a platform are all avenues for biotech to pursue to align with pharma and investor expectations.
Date and Time: Wednesday, 09 September 2026 at 07:00 – Thursday, 10 September 2026 at 17:00
Venue details: Hotel Commonwealth, 500 Commonwealth Avenue, Boston, Massachusetts, 02215, United States
Event Organizer: Hanson Wade Conferences Ltd